Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
MD VIROLOGIST's Profile
Displaying 301-350 of 672 result(s).
CYDY CytoDyn Inc
01/18/2021 10:41:51 PM
Exactly, sub-q dosing is always pro (3)
CYDY CytoDyn Inc
01/18/2021 6:44:11 PM
I have a dream, that soon a therape (7)
CYDY CytoDyn Inc
01/18/2021 5:27:17 PM
And even more variability during il
CYDY CytoDyn Inc
01/18/2021 4:29:51 PM
For example some were 100% at three
CYDY CytoDyn Inc
01/18/2021 3:13:36 PM
Nothing published, yet, and those w (1)
CYDY CytoDyn Inc
01/18/2021 2:54:56 PM
There could be many reasons, BP's o (2)
CYDY CytoDyn Inc
01/18/2021 12:49:22 PM
My suggestion was not have a myriad (2)
CYDY CytoDyn Inc
01/17/2021 11:06:38 PM
I simply wanted to state the protoc
CYDY CytoDyn Inc
01/17/2021 9:31:04 PM
Yes if the study included RO assays (3)
CYDY CytoDyn Inc
01/14/2021 11:58:56 PM
It blocks viral entry. And aids in (1)
CYDY CytoDyn Inc
01/14/2021 11:10:56 PM
Ok let's talk in 2-4wks. (1)
CYDY CytoDyn Inc
01/14/2021 11:07:53 PM
Relief is a publically traded ADR, (1)
CYDY CytoDyn Inc
01/14/2021 11:02:27 PM
Sure, I have posted before why many (1)
CYDY CytoDyn Inc
01/14/2021 10:33:36 PM
No,in the open label study there wa (2)
CYDY CytoDyn Inc
01/14/2021 10:09:46 PM
Yes they are, they changed endpoint (2)
CYDY CytoDyn Inc
01/14/2021 12:22:04 AM
Then why did BP tweet he has a delt (1)
CYDY CytoDyn Inc
01/13/2021 7:19:12 PM
I know it is just population based (1)
CYDY CytoDyn Inc
01/13/2021 7:15:52 PM
It is virtually absent that is why (1)
CYDY CytoDyn Inc
01/13/2021 7:14:27 PM
That is exactly what I thought, unt (1)
CYDY CytoDyn Inc
01/13/2021 5:56:58 PM
They examined 102 countries, it is (1)
CYDY CytoDyn Inc
01/13/2021 5:48:08 PM
Yes why is it trash, it actually is (1)
CYDY CytoDyn Inc
01/13/2021 5:25:36 PM
https://www.ncbi.nlm.nih.gov/pmc/a (1)
CYDY CytoDyn Inc
01/11/2021 10:49:47 PM
You are one of the more credible pe
CYDY CytoDyn Inc
01/11/2021 10:15:27 PM
He will (1)
CYDY CytoDyn Inc
01/11/2021 10:10:06 PM
He doesn't care if everything he te
CYDY CytoDyn Inc
01/11/2021 9:58:44 PM
He doesn't want to convince, just w
CYDY CytoDyn Inc
01/11/2021 9:16:36 PM
Yes he wants (BP) to codify some of (1)
CYDY CytoDyn Inc
01/11/2021 8:51:47 PM
Never said fatal just important,
CYDY CytoDyn Inc
01/11/2021 8:49:27 PM
Unfortunately because of the crisis (1)
CYDY CytoDyn Inc
01/11/2021 6:40:02 PM
It is an idiosyncratic reaction but (1)
CYDY CytoDyn Inc
01/11/2021 6:35:44 PM
He does. That is why he thinks it i (1)
CYDY CytoDyn Inc
01/11/2021 6:30:57 PM
We could here a statement that at x (1)
CYDY CytoDyn Inc
01/11/2021 6:27:25 PM
The drug is safe, this in clinical (1)
CYDY CytoDyn Inc
01/11/2021 6:25:50 PM
What if a dose three days later cre (1)
CYDY CytoDyn Inc
01/11/2021 6:22:53 PM
Right but what if dosing becomes gu
CYDY CytoDyn Inc
01/11/2021 3:59:03 PM
Half of cardiac transplants are for
CYDY CytoDyn Inc
01/11/2021 3:51:35 PM
all viruses can cause that.
CYDY CytoDyn Inc
01/11/2021 3:46:31 PM
For example if patients with the hi (1)
CYDY CytoDyn Inc
01/11/2021 3:29:27 PM
I am not bashing, RO is a powerful
CYDY CytoDyn Inc
01/11/2021 3:22:18 PM
Thank you for your patience.
CYDY CytoDyn Inc
01/11/2021 3:21:22 PM
Sorry, not trying to be offensive, (2)
CYDY CytoDyn Inc
01/11/2021 3:07:14 PM
If the lack of that data point is n (1)
CYDY CytoDyn Inc
01/11/2021 10:21:09 AM
To the best of my knowledge they ha
CYDY CytoDyn Inc
01/11/2021 9:22:26 AM
He is not, and NP has not told us t
CYDY CytoDyn Inc
01/10/2021 10:44:18 PM
You are right, in response, to anot
CYDY CytoDyn Inc
01/10/2021 7:23:15 PM
Plus not all PI's are prompt and it (1)
CYDY CytoDyn Inc
01/10/2021 6:24:37 PM
This not a bash or coming from a sh (3)
CYDY CytoDyn Inc
01/10/2021 1:27:28 PM
I agree probably not till February (1)
CYDY CytoDyn Inc
01/09/2021 7:17:55 PM
Remember after the press hype about
CYDY CytoDyn Inc
01/09/2021 6:03:24 PM
You are spot on especially # 4. Par (1)
Go to page:
  • << First
  • < Previous
  • 6
  • 7
  • Next >

Recent Articles

  • Risetcar's Autonomous Taxis Set to Transform Jakarta's Transport
  • Pan-Mass Challenge: Cyclists Unite for Groundbreaking Research
  • Bitcoin Swift Presale Enters New Phase with Innovative AI Rewards
  • Celebrating Financial Health: Global Impact Champions Awards Launch
  • Avast Emerges as the Top Choice for Antivirus Software
  • FAA Implements Changes to Helicopter Routes after Tragedy
  • Navigating High-Beta Stocks: Echoes of the Dot-Com Boom
  • Understanding the Real Dynamics Behind Portfolio Performance
  • Overview of Financière de Tubize’s Half-Year Performance
  • Financière de Tubize Unveils Promising Financial Results for 2025
  • Legal Actions from Shareholders: Insights on Sarepta and Petco
  • Kuvi.ai Unveils Agentic Finance OS in Seed Funding Expansion
  • SHARC Energy Advancing Financing with New Convertible Debentures
  • Important Class Action Update for Hims & Hers Health Investors
  • Class Action Lawsuit Emerges Against Flywire Corporation
  • Important Update for Sable Offshore Investors: Act Now
  • Class Action Notice for Neogen Investors: Key Details Inside
  • Tempus AI Faces Legal Challenges Following SEC Allegations
  • Replimune Group Faces Class Action: Key Insights for Investors
  • Neogen Corporation Investors Can Join Class Action Efforts
  • Key Actions for Luminar Technologies Investors Amid Class Action
  • Investors Urged to Act: RxSight Class Action Deadline Approaches
  • Sable Offshore Corp. Class Action: Important Actions for Investors
  • Protecting Your Rights Following Securities Claims with TRSG
  • Investors of Fiserv, Inc. Can Join Class Action for Losses
  • Kepler's K2 Humanoid Robot Revolutionizes Industrial Automation
  • Investor Rights Firm Investigates Potential Mergers and Sales
  • Investigating Stockholder Rights: Olo, Fubo, Arcadia, and Norfolk
  • RxSight Inc. Faces Class Action Lawsuit Over Misleading Claims
  • Spitzer Autoworld Elevates Customer Experience with New VIP Program
  • HashJ Launches New BTC Participation Contracts Amid Market Shift
  • Experience Vibrant Music Events at Great Park Live This Season
  • Explore OLIVE YOUNG's K-Beauty Innovations at KCON LA 2025
  • Discovering the Exceptional Growth of Gartner Stock Today
  • Investors of Sable Offshore Corp. Encouraged to File Claims
  • Senate Bill Secures Funding for OSHA and NIOSH - A Win for Safety
  • Arteris, Inc. Boosts Team with New Inducement Stock Awards
  • Investing in Ameriprise Financial: A 5-Year Review
  • Grupo Cox Makes Major Investment with Iberdrola Acquisition
  • First National Bank Alaska Announces Strong Q3 Dividend Strategy
  • Understanding the Long-Term Value of American Express Stock
  • First National Bank Alaska Announces Third Quarter Dividend
  • Project 61 and Offshift Join Forces for Truck Driver Health
  • Keg Royalties Income Fund Secures Approval for Fairfax Deal
  • The Keg Royalties Income Fund Secures Approval for Key Deal
  • Unlocking the Wealth from Shopify: 15 Years of Growth Insights
  • Lara's Rate Hikes: Consumers Left in Uncertainty Amid Secrecy
  • Barrett-Jackson Holdings Responds to Customer Data Breach
  • A Decade of Growth: $100 in Live Nation Entertainment's Journey
  • Crypto Market Surges—Will the Bull Momentum Continue?
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site